Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN) Meeting Abstract


Authors: Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; Theodoulou, M.; Sklarin, N.; Uhlenhopp, M.; Yao, T. J.; Norton, L.
Abstract Title: Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
Meeting Title: 19th Annual San Antonio Breast Cancer Symposium
Keywords: doxorubicin; paclitaxel; breast cancer; cyclophosphamide; oncology; pharmacology; patient; antineoplastic-drug; event-free survival; neoplastic disease; female; positive axillary nodes; reproductive system disease/female; dose-dense drug treatment
Journal Title: Breast Cancer Research and Treatment
Volume: 41
Issue: 3
Meeting Dates: 1996 Dec 11-14
Meeting Location: San Antonio, TX
ISSN: 0167-6806
Publisher: Springer  
Date Published: 1996-10-01
Start Page: 232
Language: English
ACCESSION: BCI:BCI199799402389
PROVIDER: biosis
PUBMED: 8978421
DOI: 10.1007/BF01806166
Notes: Meeting abstract: 128 -- Source: Biosis
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Seidman
    318 Seidman
  2. Mary Ellen Moynahan
    105 Moynahan
  3. Clifford Hudis
    905 Hudis
  4. Larry Norton
    758 Norton
  5. Nancy T Sklarin
    54 Sklarin
  6. Tzy-Jyun Yao
    59 Yao
  7. Violante Currie
    51 Currie
  8. Jose T Baselga
    484 Baselga
  9. Antonella   Surbone
    33 Surbone
  10. George   Raptis
    29 Raptis
  11. David Lebwohl
    28 Lebwohl